- Home
- IHT vs IMNN Comparison
IHT vs IMNN Comparison
Compare IHT & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHT
- IMNN
- Stock Information
- Founded
- IHT 1971
- IMNN 1982
- Country
- IHT United States
- IMNN United States
- Employees
- IHT N/A
- IMNN N/A
- Industry
- IHT Investment Bankers/Brokers/Service
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- IHT Finance
- IMNN Health Care
- Exchange
- IHT Nasdaq
- IMNN Nasdaq
- Market Cap
- IHT 20.2M
- IMNN 12.1M
- IPO Year
- IHT N/A
- IMNN 1985
- Fundamental
- Price
- IHT $2.19
- IMNN $0.80
- Analyst Decision
- IHT
- IMNN Buy
- Analyst Count
- IHT 0
- IMNN 2
- Target Price
- IHT N/A
- IMNN $14.00
- AVG Volume (30 Days)
- IHT 1.7K
- IMNN 2.6M
- Earning Date
- IHT 07-11-2025
- IMNN 08-13-2025
- Dividend Yield
- IHT 0.92%
- IMNN N/A
- EPS Growth
- IHT N/A
- IMNN N/A
- EPS
- IHT N/A
- IMNN N/A
- Revenue
- IHT $7,505,309.00
- IMNN N/A
- Revenue This Year
- IHT N/A
- IMNN N/A
- Revenue Next Year
- IHT N/A
- IMNN N/A
- P/E Ratio
- IHT N/A
- IMNN N/A
- Revenue Growth
- IHT N/A
- IMNN N/A
- 52 Week Low
- IHT $1.34
- IMNN $0.37
- 52 Week High
- IHT $2.70
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- IHT 38.16
- IMNN 41.12
- Support Level
- IHT $2.16
- IMNN $0.70
- Resistance Level
- IHT $2.35
- IMNN $0.86
- Average True Range (ATR)
- IHT 0.06
- IMNN 0.10
- MACD
- IHT -0.00
- IMNN -0.06
- Stochastic Oscillator
- IHT 15.79
- IMNN 10.31
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).